StockTipsArenaBeta

BUY Sun Pharmaceutical Industries Ltd. — Ajit Mishra, Religare

BUYSun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries share price target & all analyst calls
⏳ Pending entry — level not yet reached

byAjit Mishra, ReligareHorizon: NA (inferred 1 year)12 Nov 2026via ET Now (Live)

Entry₹1,800Stated
Target₹2,020
Total upside +12.22%
Stop lossNot given
CMP₹1,8801d ago
ActiveNA 12 mo left
Follow Ajit Mishra for new callsGet alertsWatch SUNPHARMA for new buy/sell callsGet alertsSee 25 other Long-term calls on SUNPHARMASee 272 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 15 Nov, 3:36 am IST
11 supporting6 neutral1 opposing
Supports the BUY call (11)

Long-term trend bullish — 200-day average rising over the past quarter

Technicals · trend·13 Nov · yesterday

Muhurat Trading 2026: Finolex Cables Jumps 17% As Samvat 2083 Begins. These Stocks Are Also Rallying

NewsNdtv-Profit·8 Nov · 6d ago

(opens in new tab)

1 advisor has an active short-term BUY call on this stock, issued in the last 14 days

Advisor consensus · adjacent horizon·7 Nov · 1w ago

20 other SEBI-registered advisors have active long-term BUY calls on this stock, with 8 issued in the last 14 days

Advisor consensus · same horizon·2 Nov · 2w ago

Sun Pharma shares extend 4-day rally after USFDA approval for ILUMYA in arthritis patients

NewsCnbc-Tv18·30 Oct · 2w ago

(opens in new tab)
Neutral / worth noting (6)

Unaudited Financial Results for the quarter and half year ended 30 September 2026

NSE · Outcome of Board Meeting·30 Oct · 2w ago

(opens in new tab)

Sun Pharma to raise Rs 10,000 crore to part-finance Organon deal

NewsEt-Markets·21 Oct · 3w ago

(opens in new tab)

Pharma Q2 Outlook: Pricing pressure, US competition to weigh on select players

NewsEt-Markets·19 Oct · 4w ago

(opens in new tab)
Weighs against the BUY call (1)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Sun Pharmaceutical Industries

All analyst calls on Sun Pharmaceutical Industries

More from Ajit Mishra, Religare

Every call and its outcome